PMID: 11337217May 5, 2001Paper

Pharmacologic treatment of diabetes in long-term care

Journal of Clinical Epidemiology
J J SpoonerG Gambassi

Abstract

The majority of patients with diabetes are elderly, but little is known about their disease management. This study evaluates the prevalence and correlates of treatment of elderly diabetics residing in long-term care. We performed a retrospective, cross-sectional study of 75,829 elderly diabetics residing in nursing homes from 1992 to 1996. Nearly half (47%) of the residents received no antidiabetic medications. Independent predictors not receiving antidiabetic medications included age, race, impaired physical ability, and impaired cognitive function. Although the absence of resident's blood glucose or glycosylated hemoglobin (HbA1c) values prevents us from passing judgment about the adequacy of diabetic care, further research is needed to understand why some residents do not receive antidiabetic medications in the long-term care setting.

References

Aug 1, 1992·The Gerontologist·C HawesJ N Morris
Apr 1, 1992·The Gerontologist·J A Teresi, D Holmes
Jun 1, 1990·The Gerontologist·J N MorrisA S Friedlob
Jan 1, 1989·Aging : Clinical and Experimental Research·A E PontiroliG Pozza
Jan 1, 1989·Journal of Clinical Epidemiology·V MorS Katz
Jul 1, 1984·Harefuah·I Steiner, Z Argov
Jul 1, 1994·Journal of Gerontology·J N MorrisL A Lipsitz
May 1, 1993·BMJ : British Medical Journal·A J Sinclair, A H Barnett
Sep 30, 1993·The New England Journal of Medicine·R D Lasker
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Aug 1, 1996·Annals of Internal Medicine·R B BurnsM A Moskowitz
Jun 28, 1997·BMJ : British Medical Journal·S J BenbowG V Gill
Oct 20, 1998·American Journal of Surgery·W K StadelmannG R Tobin
Aug 28, 1999·Journal of Clinical Epidemiology·R J GlynnJ Avorn
Dec 28, 2002·Diabetes Care·Saul GenuthUNKNOWN American Diabetes Association

❮ Previous
Next ❯

Citations

Apr 29, 2009·Archives of Internal Medicine·Matthew D SolomonJosé J Escarce
Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Jul 3, 2007·Pharmacy World & Science : PWS·Susan M PattersonKate L Lapane
Apr 4, 2002·PharmacoEconomics·Kate L Lapane, Carmel M Hughes
May 31, 2012·Drugs & Aging·Antonio CherubiniFabrizia Lattanzio
May 21, 2011·The American Journal of Geriatric Pharmacotherapy·Jessica J JalbertKate L Lapane
Aug 12, 2003·Diabetes & Metabolism·M PhamI Bourdel-Marchasson
Feb 10, 2011·International Journal of Older People Nursing·Carole ParsonsCarmel Hughes
Feb 10, 2011·International Journal of Older People Nursing·Carole ParsonsCarmel Hughes
Sep 26, 2006·Social Science & Medicine·Susan C MillerVincent Mor
Jun 13, 2006·Journal of the American Medical Directors Association·Carmel M HughesKate L Lapane
Nov 16, 2005·Journal of the American Medical Directors Association·Matthew K McNabneyLarry Lawhorne
Aug 18, 2009·Journal of the American Geriatrics Society·Charlene C QuinnJay Magaziner
Oct 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·E A GillM G Sutherland
Mar 29, 2011·Journal of the American Geriatrics Society·Barbara BardenheierStefan Gravenstein
Mar 15, 2014·Journal of Aging and Health·Huabin LuoM Roy Wilson
Feb 21, 2009·Medical Care Research and Review : MCRR·R Tamara Konetzka, Rachel M Werner
Mar 23, 2011·The Diabetes Educator·Theresa J Garcia, Sharon A Brown
Dec 19, 2001·International Journal of Geriatric Psychiatry·J S KennedyA Breier
Oct 31, 2003·Expert Opinion on Drug Safety·Carmel M HughesAnna Schweizer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.